Keyphrases
Irritable Bowel Syndrome
100%
Disparate Data
100%
Novel Modalities
100%
Eluxadoline
100%
Radar Plot
100%
Abdominal Pain
71%
Placebo
57%
Stool Consistency
42%
Composite Endpoint
28%
Change from Baseline
28%
Bowel Movement
28%
Opioid Antagonist
28%
Adequate Relief
28%
Abdominal Discomfort
28%
Abdominal Bloating
28%
Global Symptom Score
28%
Alleviation
14%
Placebo-controlled
14%
Phase II Study
14%
Phase II Trial
14%
Data Presentation
14%
2-phase
14%
Response Rate
14%
Twice Daily
14%
Multiple Domains
14%
Bowel Dysfunction
14%
Progress Management
14%
Efficacy Endpoint
14%
Simultaneous Improvement
14%
Rome III Criteria
14%
Abdominal Symptoms
14%
Visual Evaluation
14%
Locally Active
14%
Medicine and Dentistry
Diarrhea
100%
Irritable Bowel Syndrome
100%
Eluxadoline
100%
Abdominal Pain
83%
Placebo
83%
Bloating
33%
Abdominal Discomfort
33%
Opiate Antagonist
16%
Opiate Agonist
16%
Pharmacology, Toxicology and Pharmaceutical Science
Diarrhea
100%
Irritable Colon
100%
Eluxadoline
100%
Placebo
83%
Abdominal Pain
83%
Abdominal Discomfort
33%
Bloating
33%
Opiate Agonist
16%
Narcotic Antagonist
16%